Novel Drug Fails to Reduce Post-Op Risks

ACC Conference Reporter

ACC.17 | WASHINGTON, DC — Giving heart surgery patients investigational calcium sensitizer levosimendan pre- and perioperatively did not reduce the risk for poor outcomes, researchers reported here. Read More >>>


< Back to Listings